Literature DB >> 30916126

Diagnostic Performance of QFR for the Evaluation of Intermediate Coronary Artery Stenosis Confirmed by Fractional Flow Reserve.

Zhenhua Xing1, Junyu Pei1, Jiabing Huang1, Xinqun Hu1, Shan Gao2.   

Abstract

INTRODUCTION: Quantitative flow ratio (QFR) is a novel method enabling efficient computation of FFR from three-dimensional quantitative coronary angiography (3D QCA) and thrombolysis in myocardial infarction (TIMI) frame counting. We decided to perform a systematic review and quantitative meta-analysis of the literature to determine the correlation between the diagnosis of functionally significant stenosis obtained by QFR versus FFR and to determine the diagnostic accuracy of QFR for intermediate coronary artery stenosis.
METHODS: We searched PubMed, Embase, and Web of Science for studies concerning the diagnostic performance of QFR. Our meta-analysis was performed using the DerSimonian and Laird random effects model to determine sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR-), and diagnostic odds ratio (DOR). The sROC was used to determine diagnostic test accuracy.
RESULTS: Nine studies consisting of 1175 vessels in 1047 patients were included in our study. The pooled sensitivity, specificity, LR+, LR-, and DOR for QFR were 0.89 (95% CI: 0.86-0.92), 0.88 (95% CI: 0.86-0.91), 6.86 (95% CI,: 5.22-9.02), 0.14 (95% CI: 0.10-0.21), and 53.05 (95% CI: 29.75-94.58), respectively. The area under the summary receiver operating characteristic (sROC) curve for QFR was 0.94.
CONCLUSION: QFR is a simple, useful, and noninvasive modality for diagnosis of functional significance of intermediate coronary artery stenosis.

Entities:  

Mesh:

Year:  2019        PMID: 30916126      PMCID: PMC6436789          DOI: 10.21470/1678-9741-2018-0234

Source DB:  PubMed          Journal:  Braz J Cardiovasc Surg        ISSN: 0102-7638


INTRODUCTION

Accurate evaluation of coronary artery disease, especially intermediate coronary artery stenosis, is crucial for the evaluation of myocardial ischemia and next treatment. The gold standard for diagnosis and confirmation of functional significance of a stenosis is the fractional flow reserve (FFR). Previous studies have demonstrated that FFR-guided coronary revascularization increases the ratio of event-free survival when compared with a coronary stenosis-guided strategy[. Despite these advantages, the clinical application of FFR has been variable and slow[. FFR requires not only the hyperemic state, but also additional cost, time, and efforts. Quantitative flow ratio (QFR) is a novel method enabling efficient computation of FFR from three-dimensional quantitative coronary angiography (3D QCA) and thrombolysis in myocardial infarction (TIMI) frame counting[. Compared with FFR, QFR does not require any invasive physiological measurements, pharmacological hyperemia induction, and additional cost. The recently FAVOR (Functional Diagnostic Accuracy of Quantitative Flow Ratio in Online Assessment of Coronary Stenosis) II China study showed solid results for QFR computation in identifying the presence of functionally significant stenosis in eligible patients[. Several studies have been published in the literature addressing the correlation between the assessment of functionally significant stenosis obtained by QFR versus FFR and addressing the diagnostic accuracy of QFR for intermediate coronary artery stenosis[. The purpose of our study was to perform a systematic review and quantitative meta-analysis of the literature to determine the correlation between the diagnosis of functionally significant stenosis obtained by QFR versus FFR, and to determine the diagnostic accuracy of QFR for intermediate coronary artery stenosis.

METHODS

This protocol is reported following the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA) guidelines[. We searched PubMed, Embase, and Web of Science published before March 15, 2018. The keywords used for search were "QFR or Quantitative flow ratio". Results were limited to trials published in English. We manually searched reference lists of relevant studies and reviews, editorials, and letters to identify further articles. We used Endnote (Thompson ISI ResearchSoft, Philadelphia, USA) to manage relevant articles and remove duplicated articles.

Study Eligibility

The inclusion criteria for studies in the analysis were as follows: 1) The design was a diagnostic accuracy study; 2) The study assess the diagnostic performance of QFR compared with invasive FFR as the standard procedure; 3) Data from true positive (TP), false positive (FP), true negative (TN), false negative (FN), sensitivity and specificity can be retrieved or calculated. When relevant data were missing, authors were contacted by e-mail, before excluding the study due to inaccessibility of data.

Data Collection and Quality Assessment

Relevant data were initially extracted by two independent reviewers (Zh Xing and Jy Pei). Disagreements were resolved by consensus or by a third investigator (XQ Hu). We abstracted the following data from the selected articles: first author, publication date, study design, patient demographics; FFR threshold used to describe ischemia; and the data of TP, FP, TN, and FN. When different flow models of QFR were performed, contrast-flow QFR was preferred. Contrast-flow QFR was more accurate for predicting FFR ≤0.80 as compared with fixed-flow QFR[. Included studies were analyzed by the Quality Assessment of Diagnostic Accuracy Studies 2 (QUADAS-2)[.

Data Analysis

The inter-reviewer agreement regarding the quality assessment of included studies was assessed by the Cohen kappa test. Our meta-analysis was performed using the DerSimonian and Laird random effects model to determine sensitivity, specificity, positive likelihood ratio (LR+), negative likelihood ratio (LR), and diagnostic odds ratio (DOR). The sROC was used to determine diagnostic test accuracy. An area under the curve (AUC) between 0.75 and 0.92 represented a high degree of diagnostic accuracy, and an AUC between 0.93 and 0.96 was considered more accurate. In order to assess heterogeneity among the studies, the[ statistic was used. For[, a value >50% was considered of severe heterogeneity. The Spearman correlation coefficient was calculated to evaluate diagnostic threshold variation among the included studies. We also performed a meta-regression analysis to identify predefined potential sources of heterogeneity. All statistical analyses were completed using Meta-DiSc (version 1.4).

RESULTS

Study Selection and Characteristics

The flowchart of our search and selection process was presented in Figure 1. Our combined search strategy identified possible relevant studies. Nine studies were retrieved for a more detailed evaluation. Finally, 9 studies consisting of 1175 vessels in 1047 patients met our inclusion criteria[. Characteristics of included studies were shown in Table 1. Clinical heterogeneity was mostly due to different inclusion criteria. Mejia-Renteria[ and Emori[ included patients with myocardial infarction. Emori[ included two different populations: patients with previous myocardial infarction (MI) and patients without previous MI. Spitaleri[ included patients with ST- elevation myocardial infarction (STEMI) and multivessel disease. Four studies were performed in Japan, two in China, one each in Spain, Italy, and Netherlands. The mean (SD) age was 63.2 years, and 68.1% of the patients were male. The quality assessment of included studies according to QUADAS-2 was presented in Supplementary Figure 1. In general, there was low risk of bias and low concern regarding applicability of all included studies.
Fig. 1

Flowchart for the identification of studies.

Table 1

Characteristics of included studies.

StudyDesignCountryMean age (years)Males (%)Patients' characteristicsCutoff
Emori et al.[15]MulticenterJapan--Intermediate stenosis with FFR0.8
Xu et al.[5]Prospective, multicenterChina6173.7Intermediate stenosis with FFR0.8
Yazaki et al.[6]Retrospective, single-centerJapan72.529.6Intermediate stenosis with FFR0.8
Emori et al.[13] MI*Retrospective, single-centerJapan6983Patients with previous MI undergoing CAG and FFR0.8
Emori et al.[13]  non-MI*Retrospective, single-centerJapan7054Intermediate stenosis with FFR0.8
Tu et al.[4]Prospective, multicenterChina65.861Intermediate stenosis with FFR0.8
Kameyama et al.[11]MulticenterJapan--ACS patients with CAG and FFR0.8
van Rosendael et al.[10]Prospective, single-centerNetherlands6471Intermediate stenosis with FFR0.8
Mejia-Renteria et al.[9]MulticenterSpain--Patients with CAG and FFR0.8
Spitaleri et al.[12]Prospective, multicenterItaly6228STEMI patients with MVD and FFR0.8
Spitaleri et al.[12]Prospective, multicenterDenmark6167Intermediate stenosis with FFR0.8

Emori 2018 contained two groups: patients with previous myocardial infarction (MI) and patients with no previous MI.

ACS=acute coronary syndrome; CAG=coronary angiography; FFR=fractional flow reserve; MVD=multivessel disease; STEMI=ST-elevation myocardial infarction

Flowchart for the identification of studies. Characteristics of included studies. Emori 2018 contained two groups: patients with previous myocardial infarction (MI) and patients with no previous MI. ACS=acute coronary syndrome; CAG=coronary angiography; FFR=fractional flow reserve; MVD=multivessel disease; STEMI=ST-elevation myocardial infarction

Diagnostic Accuracy of QFR

The results of the included study were presented in Table 2. The accuracy ranged from 80% in Kameyama[ and 94% in Spitaleri, et al.[. Sensitivity ranged between 74% in Tu, et al.[ and 100% in van Rosendael, et al.[ and the specificity ranged from 79% in Emori, et al.[ to 97% in Spitaleri, et al.[. The correlation between QFR and FFR ranged from r = 0.69 to r = 0.94.
Table 2

Results of included studies in these meta-analyses.

StudyIncluded vessels (n)Sensitivity (%)Specificity (%)Accuracy (%)Correlation (r)
Emori et al.[15]738279810.69
Xu et al.[5]32894.691.792.70.86
Yazaki et al.[6]15188.789.188.70.84
Emori et al.[13] MI759282870.88
Emori et al.[13] non-MI759588920.94
Tu et al.[4]847491860.77
Kameyama et al.[11]258080800.63
van Rosendael et al.[10]1510079800.78
Mejia-Renteria et al.[9]300888687-
Spitaleri et al.[12]498897940.90

MI=myocardial infarction

Results of included studies in these meta-analyses. MI=myocardial infarction In pooled data weighted by the number of vessels, QFR had a combined sensitivity and the specificity of QFR for diagnosis of functional significance of a stenosis according to FFR were 0.89 (95% CI: 0.86-0.92) and 0.88 (95% CI: 0.86-0.91), respectively, using a random effects model (Figure 2). No heterogeneity was found for both sensitivity (I2=38.3%, P=0.10) and specificity (I2=24.1%, P=0.22). The pooled estimate of positive likelihood ratio (LR+) and negative likelihood ratio (LR-) was 6.86 (95% CI: 5.22-9.02) and 0.14 (95% CI: 0.10-0.21) (Figure 3). For QFR, Spearman's correlation coefficients were 0.619 (P=0.102), indicating that the diagnostic threshold effect did not exist in QFR data. The area under the ROC curve was 0.94 (Figure 4) and the diagnostic OR was 53.05 (95% CI: 29.75-94.58) (Supplementary Figure 2).
Fig. 2

Forest plot of the sensitivity and specificity of included study, summary sensitivity and specificity and I2 statistic for heterogeneity.

Fig. 3

Forest plot of LR+ and LR- of included study, summary sensitivity and specificity, and I2 statistic for heterogeneity.

Fig. 4

Summary receiver operating characteristic (sROC) curve for QFR.

Forest plot of the sensitivity and specificity of included study, summary sensitivity and specificity and I2 statistic for heterogeneity. Forest plot of LR+ and LR- of included study, summary sensitivity and specificity, and I2 statistic for heterogeneity. Summary receiver operating characteristic (sROC) curve for QFR.

Meta-regression Analysis and Subgroup Analysis

Meta-regression was performed using the potential sources of heterogeneity among studies (age, country, sex, different inclusion criteria). We found no factor effecting the diagnostic accuracy. Emori, et al.[ and Mejia-Renteria, et al.[ included patients with previous MI that might affect the diagnostic accuracy. Exclusion of these two trials slightly improved the specificity (0.90, 0.87-0.92), but did not affect sensitivity.

DISCUSSION

In the present study, we performed a systematic review of the diagnostic performance of QFR for functional significance of intermediate coronary artery stenosis compared with invasive FFR. Data from 1175 vessels in 1047 patients showed the situation in which QFR is helpful for surgeons to determine whether stents should be implanted at no additional cost, time, and effort. Our study is the first systemic review and meta-analysis that evaluates the diagnostic accuracy of QFR for the assessment of functionally significant stenosis confirmed by FFR. FFR-guided percutaneous coronary intervention (PCI) is associated with a better outcome compared with revascularization based on angiographic stenosis severity alone in patients with intermediate coronary artery stenosis[. FFR has the highest recommendation (class I, level A) in the European Society of Cardiology guideline on myocardial revascularization[. Although FFR has better outcomes in patients with intermediate coronary artery stenosis, the clinical application has been limited due to the invasive procedure with a pressure wire, the cost of pressure wire, and the side effects associated with induction of hyperemia. QFR, an angiographic index of coronary stenosis severity based on 3D QCA and thrombolysis in myocardial infarction (TIMI) frame counting, estimates FFR without invasive procedure[. FAVOR Pilot Study and FAVOR II China study have shown good agreement of QFR with invasive FFR[. However, the simple size was too small. Our meta-analysis included[ studies of which the majority were performed in China and Japan from 2016 to 2018, with a total of 1175 vessels in 1047patients, and demonstrated that the diagnostic accuracy of QFR for functionally significant stenosis confirmed by FFR was high, with a summary sensitivity and specificity of 0.89 (95% CI: 0.86-0.92) and 0.88 (95% CI: 0.86-0.91), respectively. Our studies included different study populations (stable coronary artery disease, suspected coronary artery disease, STEMI, previous MI). However, our meta-regression showed that different study populations did not affect our diagnostic accuracy. QFR was more often used in patients with stable coronary artery disease. A recent study has found that QFR may be a safe and reliable tool to guide revascularization in patients with STEMI and multivessel disease. Furthermore, Spitaleri found that functional complete revascularization evaluated by QFR showed a good 5-year outcome[. However, the diagnostic accuracy of QFR for assessing the functional severity of coronary stenosis might be affected in coronary arteries related to previous MI[. Microcirculatory resistance may affect this phenomenon. Mejia-Renteria, et al. found that the diagnostic accuracy of QFR was lower in patients with high microcirculatory resistance, which is supported by our subgroup analysis. Due to its specific algorithm based on QCA and TIMI frame counting, coronary collateral circulation may reduce its accuracy. Therefore, corrective measures need to be developed to improve the diagnostic accuracy in patients with previous MI or high microcirculatory resistance. Furthermore, coronary calcification or thrombus may lead to angiographic haziness which undoubtedly reduces the diagnostic accuracy of QFR. A hybrid QFR-FFR approach may be a way to overcome these limitations. Yazaki, et al.[ found that FFR should be performed in stenosis with QFR 0.75-0.85. This hybrid approach may allow clinicians to get the best of both worlds by ensuring diagnostic accuracy while reducing cost and side effects. It should be noted that our conclusion should be seen in the context of its limitation. First, the simple size is relatively small. Second, although there was no apparent heterogeneity in statistics, the heterogeneity in clinical and methodology was inevitable.

CONCLUSION

QFR is a simple, useful, and noninvasive modality for the diagnosis of functional significance of intermediate coronary artery stenosis.
Abbreviations, acronyms & symbols   
3D= Three-dimensional LR+= Positive likelihood ratio
3D QCA= Three-dimensional quantitative coronary angiography LR= Negative likelihood ratio
AUC= Area under the curve OR= Odds ratio
CI= Confidence interval MI= Myocardial infarction
DOR= Diagnostic odds ratio PCI= Percutaneous coronary intervention
EAPCI= European Association of Percutaneous Cardiovascular Interventions PRISMA= Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols
ESC= European Society of Cardiology QFR= Quantitative flow ratio
FFR= Fractional flow reserve QUADAS-2= Quality Assessment of Diagnostic Accuracy Studies 2
FP= False positive sROC= Summary receiver operating characteristic
FAVOR= Functional Diagnostic Accuracy of Quantitative Flow Ratio in Online Assessment of Coronary Stenosis study STEMI= ST-elevation myocardial infarction
FN= False negative TIMI= Thrombolysis in myocardial infarction
LR= Likelihood ratio TN= True negative
   TP= True positive
Authors' roles & responsibilities
ZXDesigned the study and provided methodological expertise; final approval of the version to be published
JPDrafted the manuscript; final approval of the version to be published
JHDrafted the manuscript; final approval of the version to be published
XHDrafted the tables and figures; final approval of the version to be published
SGDesigned the study and provided methodological expertise; final approval of the version to be published
  14 in total

1.  Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study.

Authors:  Nico H J Pijls; Pepijn van Schaardenburgh; Ganesh Manoharan; Eric Boersma; Jan-Willem Bech; Marcel van't Veer; Frits Bär; Jan Hoorntje; Jacques Koolen; William Wijns; Bernard de Bruyne
Journal:  J Am Coll Cardiol       Date:  2007-05-17       Impact factor: 24.094

2.  2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI).

Authors:  Stephan Windecker; Philippe Kolh; Fernando Alfonso; Jean-Philippe Collet; Jochen Cremer; Volkmar Falk; Gerasimos Filippatos; Christian Hamm; Stuart J Head; Peter Jüni; A Pieter Kappetein; Adnan Kastrati; Juhani Knuuti; Ulf Landmesser; Günther Laufer; Franz-Josef Neumann; Dimitrios J Richter; Patrick Schauerte; Miguel Sousa Uva; Giulio G Stefanini; David Paul Taggart; Lucia Torracca; Marco Valgimigli; William Wijns; Adam Witkowski
Journal:  Eur Heart J       Date:  2014-08-29       Impact factor: 29.983

3.  Angiographic versus functional severity of coronary artery stenoses in the FAME study fractional flow reserve versus angiography in multivessel evaluation.

Authors:  Pim A L Tonino; William F Fearon; Bernard De Bruyne; Keith G Oldroyd; Massoud A Leesar; Peter N Ver Lee; Philip A Maccarthy; Marcel Van't Veer; Nico H J Pijls
Journal:  J Am Coll Cardiol       Date:  2010-06-22       Impact factor: 24.094

4.  Quantitative Flow Ratio Identifies Nonculprit Coronary Lesions Requiring Revascularization in Patients With ST-Segment-Elevation Myocardial Infarction and Multivessel Disease.

Authors:  Giosafat Spitaleri; Matteo Tebaldi; Simone Biscaglia; Jelmer Westra; Salvatore Brugaletta; Andrea Erriquez; Giulia Passarini; Alessandro Brieda; Antonio Maria Leone; Andrea Picchi; Alfonso Ielasi; Domenico Di Girolamo; Carlo Trani; Roberto Ferrari; Johan H C Reiber; Marco Valgimigli; Manel Sabatè; Gianluca Campo
Journal:  Circ Cardiovasc Interv       Date:  2018-02       Impact factor: 6.546

5.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

6.  Fractional flow reserve versus angiography for guidance of PCI in patients with multivessel coronary artery disease (FAME): 5-year follow-up of a randomised controlled trial.

Authors:  Lokien X van Nunen; Frederik M Zimmermann; Pim A L Tonino; Emanuele Barbato; Andreas Baumbach; Thomas Engstrøm; Volker Klauss; Philip A MacCarthy; Ganesh Manoharan; Keith G Oldroyd; Peter N Ver Lee; Marcel Van't Veer; William F Fearon; Bernard De Bruyne; Nico H J Pijls
Journal:  Lancet       Date:  2015-08-30       Impact factor: 79.321

7.  Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease.

Authors:  Bernard De Bruyne; Nico H J Pijls; Bindu Kalesan; Emanuele Barbato; Pim A L Tonino; Zsolt Piroth; Nikola Jagic; Sven Möbius-Winkler; Sven Mobius-Winckler; Gilles Rioufol; Nils Witt; Petr Kala; Philip MacCarthy; Thomas Engström; Keith G Oldroyd; Kreton Mavromatis; Ganesh Manoharan; Peter Verlee; Ole Frobert; Nick Curzen; Jane B Johnson; Peter Jüni; William F Fearon
Journal:  N Engl J Med       Date:  2012-08-27       Impact factor: 91.245

8.  Diagnostic Accuracy of Angiography-Based Quantitative Flow Ratio Measurements for Online Assessment of Coronary Stenosis.

Authors:  Bo Xu; Shengxian Tu; Shubin Qiao; Xinkai Qu; Yundai Chen; Junqing Yang; Lijun Guo; Zhongwei Sun; Zehang Li; Feng Tian; Weiyi Fang; Jiyan Chen; Wei Li; Changdong Guan; Niels R Holm; William Wijns; Shengshou Hu
Journal:  J Am Coll Cardiol       Date:  2017-10-31       Impact factor: 24.094

9.  Diagnostic Accuracy of Fast Computational Approaches to Derive Fractional Flow Reserve From Diagnostic Coronary Angiography: The International Multicenter FAVOR Pilot Study.

Authors:  Shengxian Tu; Jelmer Westra; Junqing Yang; Clemens von Birgelen; Angela Ferrara; Mariano Pellicano; Holger Nef; Matteo Tebaldi; Yoshinobu Murasato; Alexandra Lansky; Emanuele Barbato; Liefke C van der Heijden; Johan H C Reiber; Niels R Holm; William Wijns
Journal:  JACC Cardiovasc Interv       Date:  2016-10-10       Impact factor: 11.195

10.  Accuracy and reproducibility of fast fractional flow reserve computation from invasive coronary angiography.

Authors:  A R van Rosendael; G Koning; A C Dimitriu-Leen; J M Smit; J M Montero-Cabezas; F van der Kley; J W Jukema; J H C Reiber; J J Bax; A J H A Scholte
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-22       Impact factor: 2.357

View more
  2 in total

1.  Fractional flow reserve, quantitative flow ratio, and instantaneous wave-free ratio: a comparison of the procedure-related dose of ionising radiation.

Authors:  Greta Ziubryte; Gediminas Jarusevicius
Journal:  Postepy Kardiol Interwencyjnej       Date:  2021-03-27       Impact factor: 1.426

2.  Quantitative Flow Ratio or Angiography for the Assessment of Non-culprit Lesions in Acute Coronary Syndromes: Protocol of the Randomized Trial QUOMODO.

Authors:  Helen Ullrich; Maximilian Olschewski; Khelifa-Anis Belhadj; Thomas Münzel; Tommaso Gori
Journal:  Front Cardiovasc Med       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.